KOVAIKovai Medical Center & Hospital Limited
Healthcare · Medical Care Facilities · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Kovai Medical Center and Hospital Limited operates a multi-speciality hospital primarily in India. The company operates in two segments, Healthcare Services and Education Services. It operates various medical facilities, which provide services related to emergency and trauma care, cardiology, oncology, gynaecology and obstetrics, radiology, transplant, neurology, as well as orthopaedics and joint replacement, gastroenterology and haematology, pediatrics, endocrinology, diabetes management, rheumatology, pulmonology, psychiatry, cosmetic surgery, ENT, dermatology, hematology, urology, nephrology, and paediatrics. The company also offers preventive health check-ups and wellbeing programs. In addition, it operates a medical college in Coimbatore. The company serves out-patients, in-patients, and common public. Kovai Medical Center and Hospital Limited was incorporated in 1985 and is based in Coimbatore, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on KOVAI — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why buy
- • ROE: 20.3%
- • ROCE: 19.1%
- • Debt/Equity: 0.31
- • RSI: 59
- • MACD: bullish
- • Price vs EMA21: above
Bull case
- • ROE: 20.3%
- • ROCE: 19.1%
- • Debt/Equity: 0.31
- • RSI: 59
Bear case
- • Dividend yield: 0.00%
- • Volume: 1.0x 20-day average
- • Volume trend: 0.9x baseline
- • Volatility: 117% annualized
Key risks
- • Dividend yield: 0.00%
- • Volume: 1.0x 20-day average
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹160.53). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.